Abstract
Outcome in SLE patients should include assessment of disease activity and chronic damage and also measurement of health-related quality of life and the economic impact of the disease. This paper reviews the methods available for doing this and the results of existing studies in SLE patients.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anxiety
-
Canada
-
Clinical Trials as Topic / methods*
-
Costs and Cost Analysis
-
Depression
-
Europe
-
Fatigue
-
Health Status
-
Health Status Indicators
-
Humans
-
Lupus Erythematosus, Systemic / economics
-
Lupus Erythematosus, Systemic / physiopathology
-
Lupus Erythematosus, Systemic / psychology
-
Lupus Erythematosus, Systemic / therapy*
-
Quality of Life*
-
Surveys and Questionnaires
-
Treatment Outcome